Conference
AML-303: Systematic Review of Frailty Assessment Tools for Elderly Patients with Acute Myeloid Leukemia
Abstract
Context Treating elderly AML patients (>65 years) with intensive remission-induction chemotherapy without proper frailty assessment results in poor survival. We hypothesize a lack of health status measurement tools specific for elderly AML patients that inform risk stratification and treatment decisions. Objective To determine the availability of frailty assessment tools for elderly AML patients. Methods We searched MEDLINE, EMBASE, PsycINFO …
Authors
Khalaf D; Berg T; Hillis C; Kouroukis T; Leber B; Lee J
Volume
20
Publisher
Elsevier
Publication Date
September 2020
DOI
10.1016/s2152-2650(20)30751-5
Conference proceedings
Clinical Lymphoma Myeloma & Leukemia
ISSN
2152-2650